StockData
MetaVia Inc. logo

MetaVia Inc. (MTVA) stock

MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.25+0.04 (+3.73%)

Close on Nov 17, 2026Market cap $8.24MP/E –Yield –

MetaVia operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MetaVia's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.84M. For fiscal 2025 it was -$15.70M. The highest annual figure on record is -$195.00K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.70M–
FY2024Dec 31, 2024-$24.71M–
FY2023Dec 31, 2023-$10.80M–
FY2022Dec 31, 2022-$11.71M–
FY2021Dec 31, 2021-$15.13M–
FY2020Dec 31, 2020-$10.76M–
FY2019Dec 31, 2019-$7.04M–
FY2018Dec 31, 2018-$14.45M–
FY2017Dec 31, 2017-$26.90M–
FY2016Dec 31, 2016-$11.04M–
FY2015Dec 31, 2015-$5.43M–
FY2014Dec 31, 2014-$195.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.76M–
Q1 FY2026Mar 31, 2026-$4.26M–
Q4 FY2025Dec 31, 2025-$4.86M–
Q3 FY2025Sep 30, 2025-$2.96M–
Q2 FY2025Jun 30, 2025-$3.07M–
Q1 FY2025Mar 31, 2025-$4.82M–
Q4 FY2024Dec 31, 2024-$5.47M–
Q3 FY2024Sep 30, 2024-$5.55M–
Q2 FY2024Jun 30, 2024-$7.25M–
Q1 FY2024Mar 31, 2024-$6.44M–
Q4 FY2023Dec 31, 2023-$3.39M–
Q3 FY2023Sep 30, 2023-$2.81M–
Q2 FY2023Jun 30, 2023-$2.05M–
Q1 FY2023Mar 31, 2023-$2.55M–
Q4 FY2022Dec 31, 2022-$1.81M–
Q3 FY2022Sep 30, 2022-$2.36M–
Q2 FY2022Jun 30, 2022-$2.72M–
Q1 FY2022Mar 31, 2022-$4.83M–
Q4 FY2021Dec 31, 2021-$2.90M–
Q3 FY2021Sep 30, 2021-$2.51M–
Q2 FY2021Jun 30, 2021-$3.59M–
Q1 FY2021Mar 31, 2021-$6.14M–
Q4 FY2020Dec 31, 2020-$2.35M–
Q3 FY2020Sep 30, 2020-$1.95M–
Q2 FY2020Jun 30, 2020-$2.32M–
Q1 FY2020Mar 31, 2020-$4.14M–
Q4 FY2019Dec 31, 2019-$1.28M-138.2%
Q3 FY2019Sep 30, 2019-$3.35M–
Q2 FY2019Jun 30, 2019-$1.19M–
Q1 FY2019Mar 31, 2019-$1.22M–
Q4 FY2018Dec 31, 2018$3.35M–
Q3 FY2018Sep 30, 2018-$4.28M–
Q2 FY2018Jun 30, 2018-$6.28M–
Q1 FY2018Mar 31, 2018-$7.24M–
Q4 FY2017Dec 31, 2017-$6.76M–
Q3 FY2017Sep 30, 2017-$7.30M–
Q2 FY2017Jun 30, 2017-$6.62M–
Q1 FY2017Mar 31, 2017-$6.22M–
Q4 FY2016Dec 31, 2016-$3.62M–
Q3 FY2016Sep 30, 2016-$3.63M–

More MetaVia figures

See a number that looks wrong?